2. UroToday Home
  3. Video Lectures

Journal Club Videos

UpFrontPSMA Trial Results: Lutetium-177 PSMA-617 in Hormone-Sensitive Prostate Cancer, Journal Club - Phillip Koo & Zachary Klaassen
October 15, 2024
Details
ARANOTE Trial Implications for Metastatic Prostate Cancer Management, Journal Club - Rashid Sayyid & Zachary Klaassen
October 12, 2024
Details
Cardiovascular Risks of ARSIs in Prostate Cancer: Meta-Analysis Findings, Journal Club - Rashid Sayyid & Zachary Klaassen
August 23, 2024
Details
2024 NCCN Guidelines: Managing Bone Health in Prostate Cancer Patients - Rashid Sayyid & Zachary Klaassen
July 26, 2024
Details
2024 NCCN Guidelines: Preventing Skeletal Events in Prostate Cancer - Rashid Sayyid & Zachary Klaassen
July 25, 2024
Details
PI-CAI Challenge: AI vs Radiologists in Prostate Cancer MRI Detection, Journal Club - Rashid Sayyid & Zachary Klaassen
July 9, 2024
Details
NCCN 2024 Prostate Cancer Guidelines Update: PARP Inhibitors in Focus - Rashid Sayyid & Zachary Klaassen
May 22, 2024
Details
Evaluating a Sequential Screening Approach for Prostate Cancer Using PSA, Kallikrein Panel, and MRI in the ProScreen Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
May 7, 2024
Details
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
March 19, 2024
Details
ARASENS Subgroup Analysis on Triplet Therapy Improves Outcomes for Black Patients with mHSPC, Journal Club - Rashid Sayyid & Zachary Klaassen
March 11, 2024
Details
ProtecT Trial 15-Year Data Shows Low Prostate Cancer Mortality Across Therapies for Localized Disease, A Journal Club for Patients with Prostate Cancer - Matthew Cooperberg
January 18, 2024
Details
Discussion Between Expert Clinicians and Patients on the ProtecT Trial, A Journal Club for Patients with Prostate Cancer - Matthew Cooperberg
January 18, 2024
Details
Consensus Recommendations to Optimize Low and Intermediate-Risk Bladder Cancer Studies, Journal Club - Rashid Sayyid & Zachary Klaassen
January 3, 2024
Details
International Panel Defines Endpoints and Control Arms for Trials in Locally Advanced and Metastatic Bladder Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
January 3, 2024
Details
Leaders Establish Consensus Criteria for High-Risk Bladder Cancer Trials, Journal Club - Rashid Sayyid & Zachary Klaassen
December 21, 2023
Details
Multi-Disciplinary Panel Defines Clinical Trial Framework for Muscle-Invasive Bladder Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
December 21, 2023
Details
Reviewing Evidence on Bone Health and Future Directions in Updated Prostate Cancer Guidelines, Journal Club - Rashid Sayyid & Zachary Klaassen
December 20, 2023
Details
Guideline Revisions Seek to Optimize Detection and Management of Recurrent Prostate Cancer Without Evident Metastasis, Journal Club - Rashid Sayyid & Zachary Klaassen
December 20, 2023
Details
From Epidemiology to Surgery: A Comprehensive Look at AUA's BPH Guidelines, Journal Club - Rashid Sayyid & Zachary Klaassen
December 20, 2023
Details
Review of Medical Therapy Options in Updated AUA Guidelines for BPH Management, Journal Club - Rashid Sayyid & Zachary Klaassen
December 19, 2023
Details
AUA's Surgical Guidelines for BPH: From Patient Assessment to Procedure Selection, Journal Club - Rashid Sayyid & Zachary Klaassen
December 18, 2023
Details
Examining Expert Recommendations Seeking to Update Outdated Standards in BPH Evaluation and Management, Journal Club - Rashid Sayyid & Zachary Klaassen
December 18, 2023
Details
Epidemiological Trends and Treatment Innovations in Advanced Prostate Cancer: An In-Depth Analysis of the AUA's Amended 2023 Guidelines, Journal Club - Rashid Sayyid & Zachary Klaassen
December 15, 2023
Details
Triple-Drug Therapies Usher in Sea Change for Men With High-Risk Prostate Cancer - Rashid Sayyid & Zachary Klaassen
December 15, 2023
Details
Expert Guidelines Detail Optimal Sequencing of Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
December 15, 2023
Details
AUA Guidelines Provide Roadmap for Assessing Disease Burden and Personalizing Systemic Therapies in Metastatic Hormone Sensitive Prostate Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
December 15, 2023
Details
Risk Stratification and Pre-Surgical Assessments According to AUA Guidelines for Upper Tract Urothelial Carcinoma, Journal Club - Rashid Sayyid & Zachary Klaassen
October 25, 2023
Details
Unpacking the AUA Guidelines: Neoadjuvant Chemotherapy and Surveillance in Non-Metastatic Upper Tract Urothelial Carcinoma, Journal Club - Rashid Sayyid & Zachary Klaassen
October 25, 2023
Details
Exploring Kidney-Sparing Management: An In-Depth Look at Tumor Ablation Techniques, AUA Guidelines, and the Role of Jelmyto in Upper Tract Urothelial Carcinoma, Journal Club - Rashid Sayyid & Zachary Klaassen
October 16, 2023
Details
KEYNOTE-B61 Trial Reveals Promising Results for Pembrolizumab and Lenvatinib Combination in Advanced Non-Clear Cell Renal Cell Carcinoma, Journal Club - Rashid Sayyid & Zachary Klaassen
September 12, 2023
Details
How Race Influences Trust in Online Prostate Cancer Content, Journal Club - Rashid Sayyid & Zachary Klaassen
August 30, 2023
Details
Agent Orange Exposure and Bladder Cancer Risk: A Comprehensive Study Among US Veterans, Journal Club - Rashid Sayyid & Zachary Klaassen
August 25, 2023
Details
A New Approach to Bladder Cancer: The ATLAS Trial's Exploration of UGN-102 and TURBT, Journal Club - Rashid Sayyid & Zachary Klaassen
August 25, 2023
Details
A Comprehensive Look at Genomic Classifier Performance in Intermediate Risk Prostate Cancer: Insights from the NRG Oncology/RTOG 01-26 Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
August 22, 2023
Details
A Head-to-Head Comparison: 68 Gallium-NODAGA-JR11 and 68 Gallium-DOTATATE PET/CT in Neuroendocrine Tumors, Journal Club - Rashid Sayyid & Zachary Klaassen
August 22, 2023
Details
TRAVERSE Trial Insights: A Comprehensive Look at Testosterone Replacement Therapy and Cardiovascular Safety, Journal Club - Rashid Sayyid & Zachary Klaassen
August 22, 2023
Details
The ACDC-RP Phase II Trial: Understanding the Impact on High-Risk Prostate Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
August 21, 2023
Details
A Leap Forward in Prostate Cancer Care: AI Model Guides Individualized Hormone Therapy Decisions, Journal Club - Rashid Sayyid & Zachary Klaassen
August 3, 2023
Details
Transcriptomic and Clinical Heterogeneity in Metastatic Castration-Sensitive Prostate Cancer: Unraveling the Molecular Landscape, Journal Club - Rashid Sayyid & Zachary Klaassen
August 2, 2023
Details
AR and PI3K Genomic Profiling in Lutetium-177-PSMA Treatment: A Pathway to Identifying Poor Responders, Journal Club - Rashid Sayyid & Zachary Klaassen
August 2, 2023
Details
Tailoring Treatment Strategies: How a Nomogram Guides PSMA-PET Salvage Radiotherapy, Journal Club - Rashid Sayyid & Zachary Klaassen
August 2, 2023
Details
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
July 25, 2023
Details
Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare, Journal Club - Rashid Sayyid & Zachary Klaassen
July 25, 2023
Details
Oligometastatic Prostate Cancer: Unraveling Differences Between Imaging Techniques, Journal Club - Rashid Sayyid & Zachary Klaassen
July 24, 2023
Details
No Benefit from Checkpoint Inhibitor Rechallenge: Key Findings from CONTACT-03 Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
July 24, 2023
Details
The Future of Kidney Cancer Treatment: COSMIC-313 Trial Breakdown, Journal Club - Rashid Sayyid & Zachary Klaassen
July 24, 2023
Details
Assessing Reader Variability in PSMA-PET/CT Scan Interpretation: A Substudy of the VISION Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
July 21, 2023
Details
Improving mCRPC Outcomes: VISION Study Highlights Lu-PSMA-617 Impact on Survival and Quality of Life, Journal Club - Rashid Sayyid & Zachary Klaassen
June 26, 2023
Details
How the TALAPRO-2 Study is Redefining First-line Treatment for Metastatic Prostate Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
June 26, 2023
Details
Exploring the Role of ATM and BRCA2 Mutations in Metastatic Prostate Cancer Outcomes, Journal Club - Rashid Sayyid & Zachary Klaassen
June 23, 2023
Details
Filling the Gap: Creating a Specialized PRO Measure for Radionuclide Therapy in Prostate Cancer, Journal Club - Zachary Klaassen & Rashid Sayyid
June 20, 2023
Details
Decoding Survival: The Role of Bone Biomarkers in Hormone-Sensitive Prostate Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
June 20, 2023
Details
The Push for PSMA-PET: Evaluating its Role in Prostate Cancer Diagnosis, Journal Club - Rashid Sayyid & Zachary Klaassen
June 16, 2023
Details
The Impact of MDT on Intermittent Hormone Therapy: Insights from the EXTEND Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
June 8, 2023
Details
Ga-PSMA PET for Evaluation of Response to Chemotherapy for Metastatic Prostate Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
June 7, 2023
Details
Evaluating Outcomes of Enzalutamide and Abiraterone Co-administration: Insights from the ALLIANCE Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
June 5, 2023
Details
Two-Year Follow-Up: Avelumab Improves Survival in Advanced Urothelial Carcinoma, Journal Club - Rashid Sayyid & Zachary Klaassen
June 5, 2023
Details
Comparative Analysis of Radical Cystectomy and Trimodality Therapy for Muscle-Invasive Bladder Cancer, Journal Club – Rashid Sayyid & Zachary Klaassen
June 5, 2023
Details
Examining Survival Rates in Prostate Cancer: Exploring the STAMPEDE Platform, Journal Club - Rashid Sayyid & Zachary Klaassen
June 5, 2023
Details
Racial Differences in Prostate Cancer Germline Genetic Testing, Journal Club - Rashid Sayyid & Zachary Klaassen
May 31, 2023
Details
Exploring PSMA PET-Based Response's Prognostic Role in Prostate Cancer Treatment, Journal Club - Rashid Sayyid & Zachary Klaassen
May 31, 2023
Details
MARCAP Meta-Analysis of Surrogate Endpoints for Overall Survival, Journal Club - Rashid Sayyid & Zachary Klaassen
May 31, 2023
Details
Breakthrough Insights from the MAGNITUDE Study, Journal Club - Rashid Sayyid & Zachary Klaassen
April 10, 2023
Details
Crucial Insights from ENZAMET, Journal Club - Zachary Klaassen & Rashid Sayyid
April 6, 2023
Details
Functional and Quality-of-Life Impacts of Prostatectomy, Radiotherapy, and Active Monitoring: Patient-Reported Outcomes from the ProtecT Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
March 27, 2023
Details
Fifteen-Year Outcomes of Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer: Trade-offs between Benefits and Harms of Treatment Options from the ProtecT Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
March 27, 2023
Details
TP53 Variants and Prostate Cancer Risk Journal Club - Zachary Klaassen
March 23, 2023
Details
A Patient-Choice Study: Pretest Genetic Education Video vs Genetic Counseling for Men Considering Prostate Cancer Germline Testing Journal Club – Zachary Klaassen
March 23, 2023
Details
The UK Genetic Prostate Cancer Study, Family History of Prostate Cancer and Survival Outcomes Journal Club - Zachary Klaassen
March 23, 2023
Details
Changes in Rates of PSA Testing After Revisions in the USPSTF Guideline on Prostate Cancer Screening Journal Club - Zachary Klaassen
March 21, 2023
Details
Bone Mineral Density Among Older Men Receiving ADT to Treat Localized or Regional Prostate Cancer, Journal Club - Zachary Klaassen
March 9, 2023
Details
Management of Urinary Toxicity from Prostate Radiotherapy Journal Club - Zachary Klaassen
March 9, 2023
Details
NCCN 2023 Updates and Mini-Section on Quality-of-Life and Shared-Decision Making, Journal Club - Christopher J.D. Wallis & Zachary Klaassen
March 6, 2023
Details
Stockholm3 Tests to Inform Risk Stratification before MRI and Targeted Biopsies in the Prostate Cancer Screening Setting, Journal Club - Zachary Klaassen
March 4, 2023
Details
Genetic Scores as an Objective Measure of Prostate Cancer Risk To Inform Screening Decisions, a Retrospective Analysis of the Million Veteran Program, Journal Club - Zachary Klaassen
March 2, 2023
Details
Rectal Spacing With Hyaluronic Acid for Hypofractionated Radiation Therapy for Prostate Cancer, Barrigel®, Journal Club - Zachary Klaassen
March 2, 2023
Details
MRI-Guided vs CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer, The MIRAGE Randomized Clinical Trial Journal Club - Zachary Klaassen
March 2, 2023
Details
Active Surveillance as a Safe Strategy for Disease Management Among Men With Prostate Cancer: Findings From a Swedish Cohort Study, Journal Club - Zachary Klaassen
March 2, 2023
Details
Analyzing the ARASENS Trial: Darolutamide Boosts Survival in Prostate Cancer Subgroups Journal Club - Zachary Klaassen
February 27, 2023
Details
The Association of the Pandemic With Prostate Biopsy and Prostate Cancer Diagnosis Rates Among Black vs White Patients in the Veterans Affairs Health Care System Journal Club - Zachary Klaassen
February 23, 2023
Details
mpMRI What Urologists Need to Know: Targeted Biopsy - Zachary Klaassen
March 16, 2023
Details
Mediators of Racial Disparities in Prostate mpMRI Journal Club - Zachary Klaassen
February 23, 2023
Details
Dynamic Change in Patient-Reported Pain and its Association with PFS and Overall Survival in Men with De Novo Metastatic Castrate-Sensitive Prostate Cancer Journal Club - Zachary Klaassen
February 2, 2023
Details
The Efficacy of ADT Plus Androgen Receptor Axis–Targeted Therapy (ARAT) with the Triplet of ADT, ARAT, and Docetaxel in mHSPC Journal Club - Zachary Klaassen
February 2, 2023
Details
Efficacy and Safety of Darolutamide in the Planned Subgroup Analysis of the Phase 3 ARAMIS Trial, Journal Club - Zachary Klaassen
February 7, 2023
Details
The Sequencing of Short-Term ADT with Radiotherapy in Patients with Non-metastatic Prostate Cancer in the SANDSTORM Meta-Analysis, Journal Club - Zachary Klaassen
February 7, 2023
Details
Exploratory Analysis of Pain and Health-Related Quality of Life in Patients Given Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone for mCRPC, Journal Club - Zachary Klaassen
February 7, 2023
Details
The Efficacy and Safety of Abiraterone Plus Prednisone, With or Without Radiotherapy, in Addition to Standard of Care (PEACE-1): Journal Club – Zachary Klaassen
January 19, 2023
Details
5-Year Follow-Up Results From the STAMPEDE Randomised Trial: Abiraterone Acetate Plus Prednisolone for Metastatic Patients Starting Hormone Therapy: Journal Club – Zachary Klaassen
January 19, 2023
Details
The Underrepresentation of Black and Hispanic Men in Clinical Trials Compared With Their Share of Prostate Cancer Incidence: Journal Club – Zachary Klaassen
January 19, 2023
Details
Assessing Disparities in Receipt of Shorter Radiation Regimens and Treatment Noncompletion in Prostate Cancer, Journal Club - Zachary Klaassen
February 7, 2023
Details
Key Update on PARP Inhibitors from the NCCN Prostate Cancer Guidelines, Journal Club - Christopher Wallis & Zachary Klaassen
January 13, 2023
Details
What Urologists Need to Know: mpMRI for the Detection of Clinically Significant Prostate Cancer Journal Club - Zachary Klaassen
January 12, 2023
Details
SALV-ENZA Trial: Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy Journal Club - Zachary Klaassen
January 12, 2023
Details
Treatment-Specific Out-of-Pocket Costs for Patients Undergoing Localized Prostate Cancer Journal Club - Zachary Klaassen
January 5, 2023
Details
Differences in Mental Health Outcomes According to the Treatment Received for Men Being Treated with Localized Prostate Cancer Journal Club - Zachary Klaassen
January 5, 2023
Details
Using MRI to Safely Prevent Unnecessary Protocol-Advised Repeat Biopsy During Active Surveillance Journal Club - Zachary Klaassen
January 5, 2023
Details
Comparing the Relative Benefits of Radiotherapy Dose Escalation ± Short-Term or Long-Term ADT as Treatment Intensification for Localized Prostate Cancer Journal Club - Zachary Klaassen
January 5, 2023
Details
Improvement in rPFS with Abiraterone Plus Olaparib Over Abiraterone Plus Placebo in First-Line mCRPC Irrespective of HRR Mutation Status, The PROpel Trial Journal Club - Zachary Klaassen
December 21, 2022
Details
Sustained Benefit to Metastasis-Directed Therapy Versus Observation: A Pooled Analysis of the STOMP and ORIOLE Trials Journal Club - Zachary Klaassen
December 20, 2022
Details
Nivolumab/Ipilimumab (Nivo/Ipi) with or Without CBM588 in Metastatic Renal Cell Carcinoma Journal Club - Zachary Klaassen
December 15, 2022
Details
Atezolizumab as Adjuvant Therapy After Resection for Patients with Renal Cell Carcinoma with Increased Risk of Recurrence: IMmotion010 Trial, Journal Club - Zachary Klaassen
December 15, 2022
Details
10-year Results DART 01-05, High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localized Prostate Cancer Journal Club - Zachary Klaassen
December 15, 2022
Details
VIABLE Phase 3 Trial: Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With mCPRC, Journal Club - Christopher Wallis & Zachary Klaassen
December 5, 2022
Details
Electronic Symptom Monitoring During Cancer Treatment for Improved Quality of Life, Journal Club - Christopher Wallis & Zachary Klaassen
December 5, 2022
Details
223Ra Use Before 177Lu-PSMA for Patients with Bone-predominant mCRPC, The RAdium LUtetium (RALU) Study, Journal Club - Zachary Klaassen
November 30, 2022
Details
Recovery and Morbidity After Robot-Assisted Radical Cystectomy With Intracorporeal Reconstruction vs Open Radical Cystectomy, the iROC Trial, Journal Club – Christopher Wallis & Zachary Klaassen
November 18, 2022
Details
Reducing Treatment Burden For Patients with Localized GG 2 or 3 Intermediate-Risk Prostate Cancer with MRI-Guided Focused Ultrasound Focal Therapy, Journal Club - Christopher Wallis & Zachary Klaassen
November 17, 2022
Details
18F-DCFPyL PET/CT Detection Rates in Patients with Biochemical Recurrent Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
November 15, 2022
Details
The Benefit of Adding Short-Term ADT to Prostate Bed Salvage Radiotherapy to Prevent Prostate Cancer Progression, The SPPORT Trial, Journal Club - Christopher Wallis & Zachary Klaassen
November 15, 2022
Details
An Association Between Lower Facility Level PSA Screening Rates and Higher Metastatic Prostate Cancer Incidence Rates, Journal Club - Christopher Wallis & Zachary Klaassen
November 10, 2022
Details
225Ac-PSMA-617 Post ADT in mCRPC Patients: Response to Treatment and Survival Analysis, Journal Club - Christopher Wallis & Zachary Klaassen
November 9, 2022
Details
Long-Term Follow-Up Results (CheckMate 9ER) Trial, Journal Club - Christopher Wallis & Zachary Klaassen
November 18, 2022
Details
EV-201 Enfortumab Vedotin After PD-1 or PD-L1 Inhibitors in Cisplatin-Ineligible Patients with Advanced Urothelial Carcinoma, Journal Club - Christopher Wallis & Zachary Klaassen
October 12, 2022
Details
PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis, The PRIMARY Score - Journal Club - Christopher Wallis & Zachary Klaassen
October 6, 2022
Details
Trends in Incidence of Metastatic Prostate Cancer in the US - Christopher Wallis & Zachary Klaassen
October 6, 2022
Details
Optimal Treatment for Poor Prognosis Metastatic Castration-Resistant Prostate Cancer, Cabazitaxel vs Abi/Enza, Journal Club – Christopher Wallis & Zachary Klaassen
October 6, 2022
Details
Safety and Activity of Alpha-Emitting Ac-225-PSMA-617 Radioligand Therapy in mCRPC That Has Progressed After Lu-177-PSMA, Journal Club – Christopher Wallis & Zachary Klaassen
October 6, 2022
Details
The Clinical Trial Protocol of UpFront PSMA, Phase 2 Study of Sequential 177Lu‐PSMA‐617 and Docetaxel vs Docetaxel in Metastatic Hormone‐naïve Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
October 5, 2022
Details
Treatment Class-Specific Outcomes of Patients Receiving Immune Checkpoint Inhibitor vs Taxane Chemotherapy by Tumor Mutational Burden for mCRPC - Christopher Wallis & Zachary Klaassen
October 4, 2022
Details
The Role of Screening MRI To Detect Radiologic Evidence of Spinal Cord Compression With Subsequent Pre-Emptive Treatment in Men With Metastatic Castration-Resistant Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
October 3, 2022
Details
DNA Repair Genes Associated With Localized Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
September 29, 2022
Details
The Addition of Docetaxel to Radiotherapy and ADT in Nonmetastatic Unfavorable-Risk Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
January 29, 2022
Details
The Combination of PSMA + MRI vs to MRI Alone in the Diagnostic Performance for Detecting Clinically Significant Prostate Cancer (PRIMARY) - Christopher Wallis & Zachary Klaassen
September 27, 2022
Details
Molecular Subtyping and Neoadjuvant Chemotherapy in Bladder Cancer - Christopher Wallis & Zachary Klaassen
September 27, 2022
Details
Pembrolizumab Monotherapy for the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer Unresponsive to BCG the KEYNOTE-057 Study, Journal Club – Christopher Wallis & Zachary Klaassen
September 27, 2022
Details
Pembrolizumab Alone or Combined With Chemotherapy vs Chemotherapy As First-Line Therapy for Advanced Urothelial Carcinoma in the KEYNOTE-361 Trial Journal Club – Christopher Wallis & Zachary Klaassen
September 27, 2022
Details
CheckMate 274 Trial of Adjuvant Nivolumab vs Placebo in Patients Who Underwent Radical Surgery for High-Risk Muscle-Invasive Urothelial Carcinoma, Journal Club - Christopher Wallis & Zachary Klaassen
September 26, 2022
Details
CALGB 90601, Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma Journal Club - Christopher Wallis & Zachary Klaassen
September 26, 2022
Details
OMNIVORE - Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma, Journal Club - Christopher Wallis & Zachary Klaassen
September 25, 2022
Details
The Use of MRI With Targeted Biopsy in Prostate Cancer Screening Journal Club - Christopher Wallis & Zachary Klaassen
September 22, 2022
Details
225Actinium PSMA-617 and 177Lutetium PSMA-617 Tandem Therapy in mCRPC Patients, Journal Club – Christopher Wallis & Zachary Klaassen
September 22, 2022
Details
OLIGOPELVIS GETUG P07, Salvage Radiotherapy Combined With Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
September 21, 2022
Details
The First Multiplex Gene Expression Liquid Biopsy Assay to Assess Potential ARSI Resistant Mechanisms Simultaneously In the Treatment of Metastatic Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
September 21, 2022
Details
Is There Still a Role for Cytoreductive Nephrectomy? Analysis from the CARMENA Trial, Journal Club - Christopher Wallis & Zachary Klaassen
August 30, 2022
Details
Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic, Journal Club - Christopher Wallis & Zachary Klaassen
August 30, 2022
Details
Symptomatic and Health Related Quality of Life Benefits With Olaparib in Men With mCRPC Carrying Mutations in the Homologous Recombination Repair Genes, Journal Club - Christopher Wallis & Zachary Klaassen
May 24, 2022
Details
Combination Therapy Associated with Significantly Higher Rates of MFS Compared with ADT Alone Among Men with High-Risk Nonmetastatic Prostate Cancer: STAMPEDE Platform Protocol, Journal Club- Christopher Wallis & Zachary Klaassen
May 24, 2022
Details
Efficacy and Safety of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Defects (GALAHAD) Journal Club - Christopher Wallis & Zachary Klaassen
May 13, 2022
Details
The Benefit of ADT Treatment Intensification with Radiotherapy for Men with Localized Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
May 10, 2022
Details
PSMA PET CT Derived Risk-Stratification Tool for High-risk Prostate Cancer - a UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 30, 2022
Details
Racial and Ethnic Disparity in the Use of Prostate MRI - a UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 30, 2022
Details
Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence - UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 22, 2022
Details
Real-World Differences in Outcomes with First-Line Abiraterone Therapy Between African American and White Men with mCRPC - A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 22, 2022
Details
Higher Rates of Metastatic Disease on PSMA PET for Biochemical Recurrence Risk Groups, Journal Club - Christopher Wallis & Zachary Klaassen
April 14, 2022
Details
Health-Related Quality of Life- The ENZAMET Trial - A UroToday Journal Club –- Christopher Wallis & Zachary Klaassen
April 3, 2022
Details
ARASENS: A Phase 3 Trial of Darolutamide in Combination with Docetaxel for Men with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). Journal Club - Christopher Wallis & Zachary Klaassen
March 21, 2022
Details
Sequential Radiotherapy May Facilitate Deferral of Systemic Therapy Initiation in Oligometastatic Renal Cell Carcinoma, Journal Club - Christopher Wallis & Zachary Klaassen
January 19, 2022
Details
Risk Factors for Bladder Recurrence After Minimally Invasive Nephroureterectomy in UTUC, Journal Club- Christopher Wallis & Zachary Klaassen
January 19, 2022
Details
Treatment-Related Regret Among Men With Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
December 16, 2021
Details
The Efficacy of PARP inhibition in BRCA1- versus BRCA2-altered mCRPC, Journal Club - Christopher Wallis & Zachary Klaassen
December 14, 2021
Details
Variables Associated with the Use of Blue Light Cystoscopy Journal Club - Christopher Wallis & Zachary Klaassen
December 2, 2021
Details
NCCN Guideline Review on Prostate Cancer - Epidemiology, Initial Diagnosis, and Life Expectancy of Men With Prostate Cancer: Journal Club – Christopher Wallis & Zachary Klaassen
November 18, 2021
Details
NCCN Guidelines on Prostate Cancer Reviewing Advanced Prostate Cancer Neuroendocrine Disease, Bone and Visceral Metastases, and Treatment Sequencing – Christopher Wallis & Zachary Klaassen
November 12, 2021
Details
NCCN Prostate Cancer Clinical Practice Guidelines on Risk Stratification for Clinically Localized Prostate Cancer – Christopher Wallis & Zachary Klaassen
November 10, 2021
Details
Observation and Active Surveillance in the NCCN Prostate Cancer Guidelines- Christopher Wallis and Zachary Klaassen
November 9, 2021
Details
NCCN Guidelines - Staging Evaluation and Imaging Approaches in Prostate Cancer – Christopher Wallis and Zachary Klaassen
November 7, 2021
Details
NCCN Guidelines on Prostate Cancer Genetics - Christopher Wallis & Zachary Klaassen
October 31, 2021
Details
NCCN Guidelines on Prostate Cancer - A Focus on Chemotherapy, Immunotherapy, and Targeted Therapy in Advanced Prostate Cancer - Christopher Wallis and Zachary Klaassen
October 13, 2021
Details
NCCN Guidelines on Prostate Cancer: A Focus on Chemotherapy, Immunotherapy, and Targeted Therapy in Advanced Prostate Cancer - Chemotherapeutic Approaches - Christopher Wallis and Zachary Klaassen
October 13, 2021
Details
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer, The VISION Trial Journal Club - Christopher Wallis & Zachary Klaassen
October 6, 2021
Details
The Best Candidates for PSMA PET/CT as the Primary Staging Approach for High-risk Prostate Cancer - Christopher Wallis & Zachary Klaassen
October 1, 2021
Details
Long Term Use of Lutetium-177-PSMA Therapy for Men With Metastatic Castration-Resistant Prostate Cancer, Journal Club – Christopher Wallis & Zachary Klaassen
September 20, 2021
Details
Intermittent vs Continuous ADT for Patients A Review of the NCCN Guidelines – Christopher Wallis and Zachary Klaassen
September 13, 2021
Details
ADT for Castration-Naive Disease A Review of the NCCN Prostate Cancer Guidelines – Christopher Wallis and Zachary Klaassen
September 13, 2021
Details
The Cost-Effectiveness of PSMA-PET/CT When Compared with Conventional Imaging, An Analysis Informed by the proPSMA Trial - Journal Club - Christopher Wallis & Zachary Klaassen
September 10, 2021
Details
The Role of 18F-Fluciclovine-PET/CT in Improving Cancer Control Compared With Conventional Imaging Alone for Salvage Postprostatectomy Radiotherapy, the EMPIRE-1 Trial Journal Club – Christopher Wallis & Zachary Klaassen
September 10, 2021
Details
First-Line Immunotherapy, Targeted Therapy, and Combination Therapy Associated with Improved OS for Metastatic Clear Cell Renal Cell Carcinoma, Journal Club - Christopher Wallis & Zachary Klaass
September 7, 2021
Details
ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma Journal Club – Christopher Wallis & Zachary Klaassen
September 4, 2021
Details
NCCN Guidelines on Prostate Cancer: A Focus on Castration-Resistant Prostate Cancer - Christopher Wallis and Zachary Klaassen
August 31, 2021
Details
The NCCN Guidelines on Androgen Deprivation Therapy in Localized Disease, Regional Disease, and Palliative Treatment - Christopher Wallis and Zachary Klaassen
August 31, 2021
Details
Lenvatinib Plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma, The CLEAR Trial Journal Club - Christopher Wallis & Zachary Klaassen
August 12, 2021
Details
The Pattern of Metastatic Spread Impact on Efficacy of Enzalutamide - The ARCHES Study Journal Club - Christopher Wallis & Zachary Klaassen
August 12, 2021
Details
Talazoparib for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations (TALAPRO-1) Journal Club - Christopher Wallis & Zachary Klaassen
August 11, 2021
Details
Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma, Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors: TROPHY-U-01 Journal Club – Christopher Wallis & Zachary Klaassen
July 30, 2021
Details
Durvalumab Combination in Advanced Urothelial Cancer based on an Adaptive Biomarker-driven Trial Design - Christopher Wallis & Zachary Klaassen
July 27, 2021
Details
Abiraterone Acetate Plus Prednisone in Black and White Men with Metastatic Castrate-Resistant Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
July 19, 2021
Details
A Phase 1 Trial and Biomarker Analysis of HIF-2α in Renal Cell Carcinoma With Belzutifan (MK-6482), Journal Club – Christopher Wallis & Zachary Klaassen
July 19, 2021
Details
Treatment Effect of 177Lu-PSMA in Low-Volume mHSPC Patients, Journal Club – Christopher Wallis & Zachary Klaassen
July 7, 2021
Details
18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer (CONDOR) Journal Club - Christopher Wallis & Zachary Klaassen
June 28, 2021
Details
Improved Survival for Men Treated With Enzalutamide Added to Testosterone Suppression Who Present With Distant Metastases Years After Diagnosis of mHSPC Journal Club – Christopher Wallis and Zachary Klaassen
June 21, 2021
Details
The BRAVO-Feasibility Study, Intravesical Maintenance BCG vs Radical Cystectomy in BCG-Naive Patients, A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
June 13, 2021
Details
A Systematic Review of the Effectiveness and Toxicities of Lutetium-177-labeled PSMA-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Journal Presentation - Christopher Wallis & Zachary Klaassen
June 4, 2021
Details
The Diagnostic Performance of PSMA PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY) - Christopher Wallis & Zachary Klaassen
June 1, 2021
Details
Practical Considerations For the Use of Switch Maintenance Therapy: Avelumab First-Line Maintenance in Locally Advanced or Metastatic Urothelial Carcinoma Journal Club - Christopher Wallis & Zachary Klaassen
June 1, 2021
Details
Metastasis-Directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
May 8, 2021
Details
The Decipher® Genomic Classifier for Recurrent Prostate Cancer in the NRG/RTOG 9601 Randomized Clinical Trial, Journal Club - Christopher Wallis & Zachary Klaassen
May 4, 2021
Details
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma a UroToday Journal Club - Christopher Wallis and Zachary Klaassen
April 13, 2021
Details
Survivorship Care Plans Addressing Long-term Mental Health Among Survivors of Testicular Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
March 30, 2021
Details
Real-World Treatment Patterns and Health Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer (mCRPC) - Christopher Wallis and Zachary Klaassen
February 19, 2021
Details
Stereotactic Ablative Body Radiotherapy in Patients in Oligometastatic Cancers: A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
February 4, 2021
Details
Racial Disparity and Outcomes Among US Patients with Cancer and COVID-19 A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
February 2, 2021
Details
Durvalumab Vs. Chemotherapy in Previously Untreated Patients with Unresectable Metastatic Urothelial Carcinoma (DANUBE) A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
February 2, 2021
Details
Extended 4-Year Followup of CheckMate 214 Trial, Nivolumab Plus Ipilimumab for First-Line Treatment of Advanced Renal Cell Carcinoma: A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
January 29, 2021
Details
Timing of Radiotherapy After Radical Prostatectomy (RADICALS-RT) Journal Club - Zachary Klaassen and Christopher Wallis
January 24, 2021
Details
Imaging-Based Prostate Cancer Screening Among BRCA Mutation Carriers - A UroToday Journal Club
January 20, 2021
Details
Rucaparib in Men with Metastatic Castration-Resistant Prostate Cancer A Journal Club on the TRITON 2 Study - Christopher Wallis & Zachary Klaassen
January 17, 2021
Details
(TROG 08.03/ANZUP RAVES) Phase 3 Trial on Adjuvant Radiotherapy Versus Early Salvage Radiotherapy Following Radical Prostatectomy Journal Club - Christopher Wallis & Zachary Klaassen
January 2, 2021
Details
Adjuvant or Early Salvage Radiotherapy for the Treatment of Localized and Locally Advanced Prostate Cancer - The ARTISTIC Collaborative Journal Club - Christopher Wallis ad Zachary Klaassen
November 17, 2020
Details
First-Line Maintenance Avelumab in Patients with advanced Urothelial Carcinoma, A New Standard of Care - JAVELIN Bladder 100 Journal Club - Christopher Wallis & Zachary Klaassen
November 16, 2020
Details
Journal Club: Discussing Quality of Life in Patients with Metastatic Prostate Cancer Following Treatment with Cabazitaxel Versus Abiraterone or Enzalutamide - Christopher Wallis & Zachary Klaassen
October 16, 2020
Details
Significantly Longer Duration of Overall Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - PROfound Study Journal Club - Zachary Klaassen and Christopher Wallis
October 16, 2020
Details
Journal Club on Ureteroscopic Doppler Ultrasonography: Mapping Renal Blood Flow From Within the Collecting System- Evangelos Liatsikos and Roshan Patel
June 28, 2020
Details
Journal Club: The Efficacy and Safety of MitoGel™ (UGN-101) on Ablation of Upper Urinary Tract Urothelial Carcinoma (OLYMPUS) - Zachary Klaassen
June 22, 2020
Details
PROSPER Trial Journal Club: Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer - Zachary Klaassen and Christopher J.D. Wallis
June 19, 2020
Details
Journal Club: Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer - Zachary Klaassen
June 15, 2020
Details
The Impact of Treatment Delays of Upper Tract Urothelial Carcinoma (UTUC) During the COVID-19 Pandemic Journal Club - Zachary Klaassen
May 5, 2020
Details
Current and Emerging Therapies for Non-Muscle Invasive Bladder Cancer after BCG - Chris Wallis & Zach Klaassen
April 14, 2020
Details
Journal Club: The Evaluation of Cxbladder and Adjudication of Atypical Cytology - Sia Daneshmand
October 15, 2019
Details
Blue Light Cystoscopy for Diagnosis of Bladder Cancer - A Journal Club Review by Badrinath Konety
January 7, 2019
Details
Abiraterone Acetate for nmCRPC, The Forgotten Dance Partner? - Zach Klaassen and Chris Wallis
December 12, 2018
Details